rs149244006

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015102.5(NPHP4):​c.2293G>A​(p.Val765Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000729 in 1,609,728 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 3 hom. )

Consequence

NPHP4
NM_015102.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.70

Publications

4 publications found
Variant links:
Genes affected
NPHP4 (HGNC:19104): (nephrocystin 4) This gene encodes a protein involved in renal tubular development and function. This protein interacts with nephrocystin, and belongs to a multifunctional complex that is localized to actin- and microtubule-based structures. Mutations in this gene are associated with nephronophthisis type 4, a renal disease, and with Senior-Loken syndrome type 4, a combination of nephronophthisis and retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
NPHP4 Gene-Disease associations (from GenCC):
  • nephronophthisis 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen
  • Senior-Loken syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_015102.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0051927567).
BP6
Variant 1-5890879-C-T is Benign according to our data. Variant chr1-5890879-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95674.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00378 (576/152304) while in subpopulation AFR AF = 0.0127 (526/41568). AF 95% confidence interval is 0.0118. There are 1 homozygotes in GnomAd4. There are 277 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015102.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPHP4
NM_015102.5
MANE Select
c.2293G>Ap.Val765Ile
missense
Exon 17 of 30NP_055917.1O75161-1
NPHP4
NM_001291594.2
c.757G>Ap.Val253Ile
missense
Exon 13 of 26NP_001278523.1
NPHP4
NM_001291593.2
c.754G>Ap.Val252Ile
missense
Exon 14 of 27NP_001278522.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPHP4
ENST00000378156.9
TSL:1 MANE Select
c.2293G>Ap.Val765Ile
missense
Exon 17 of 30ENSP00000367398.4O75161-1
NPHP4
ENST00000378169.7
TSL:1
n.*1194G>A
non_coding_transcript_exon
Exon 14 of 27ENSP00000367411.3D6RA06
NPHP4
ENST00000466897.1
TSL:1
n.370G>A
non_coding_transcript_exon
Exon 3 of 6ENSP00000425745.1H0YA08

Frequencies

GnomAD3 genomes
AF:
0.00378
AC:
575
AN:
152186
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000902
AC:
220
AN:
244016
AF XY:
0.000836
show subpopulations
Gnomad AFR exome
AF:
0.0108
Gnomad AMR exome
AF:
0.000820
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000181
Gnomad OTH exome
AF:
0.000839
GnomAD4 exome
AF:
0.000410
AC:
598
AN:
1457424
Hom.:
3
Cov.:
31
AF XY:
0.000402
AC XY:
291
AN XY:
724428
show subpopulations
African (AFR)
AF:
0.0130
AC:
436
AN:
33426
American (AMR)
AF:
0.000900
AC:
40
AN:
44456
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26046
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39588
South Asian (SAS)
AF:
0.000829
AC:
71
AN:
85614
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52842
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5750
European-Non Finnish (NFE)
AF:
0.00000991
AC:
11
AN:
1109492
Other (OTH)
AF:
0.000648
AC:
39
AN:
60210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
26
52
77
103
129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00378
AC:
576
AN:
152304
Hom.:
1
Cov.:
32
AF XY:
0.00372
AC XY:
277
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0127
AC:
526
AN:
41568
American (AMR)
AF:
0.00242
AC:
37
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68032
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
31
63
94
126
157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00132
Hom.:
0
Bravo
AF:
0.00413
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Nephronophthisis (1)
-
-
1
Nephronophthisis 4 (1)
-
-
1
not provided (1)
-
-
1
Senior-Loken syndrome 4 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
15
DANN
Uncertain
0.98
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.76
T
MetaRNN
Benign
0.0052
T
MetaSVM
Benign
-0.51
T
MutationAssessor
Benign
1.7
L
PhyloP100
1.7
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.38
N
REVEL
Benign
0.11
Sift
Benign
0.19
T
Sift4G
Benign
0.28
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.048
gMVP
0.15
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs149244006;
hg19: chr1-5950939;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.